CDTX vs PPL · rev $1.3M vs P/E 22, rev $8.46B
Cidara Therapeutics Inc (CDTX) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
CDTX currently screens at market cap $6.96B. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the CDTX and PPL stock pages for the full models.
Not investment advice.